Concepedia

Hans G. Cruz

HG

Statistics

Publications

18

Citations

1.2K

H-Index

16

Active since

2000

Affiliations

Actelion (Switzerland)(Current)

University of Geneva

Memorial Sloan Kettering Cancer Center

Virginia Cancer Specialists

Medical College of Wisconsin

Hans G. Cruz is an author at Actelion (Switzerland) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

2000–2021

18

Publications

18

Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system

Hans G. Cruz, Tatiana Ivanova, Marie-Louise Lunn et al. · Nature Neuroscience · 2004 · 363 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

RGS2 modulates coupling between GABAB receptors and GIRK channels in dopamine neurons of the ventral tegmental area

Gwenaël Labouèbe, Marta Lomazzi, Hans G. Cruz et al. · Nature Neuroscience · 2007 · 206 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study

Mehdi Hamadani, Graham P. Collins, Paolo F. Caimi et al. · The Lancet Haematology · 2021 · 86 citations · Full text

Medicine, Immunology, Oncology +17

Absence and Rescue of Morphine Withdrawal in GIRK/Kir3 Knock-out Mice

Hans G. Cruz, Frédérique Berton, Monica Sollini et al. · Journal of Neuroscience · 2008 · 76 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel

Sandip Panicker, Hans G. Cruz, Christine Arrabit et al. · Journal of Neuroscience · 2002 · 75 citations · Full text

Natural Sciences, Biochemistry, Pharmacology +17

1–5 of 18